Back
Dyne Therapeutics Vs. Regenxbio Industry Stock Comparison
Sell
20
DYN
Dyne Therapeutics
Last Price:
$23.99
Seasonality Move:
12.85%
Sell
9
RGNX
Regenxbio
Last Price:
$7.65
Seasonality Move:
-8.12%
Sell
20
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
-
The current Dyne Therapeutics [DYN] share price is $23.99. The Score for DYN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
DYN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $23.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing slight selling pressure.
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.52 | Sell |
Relative Strength Index (14 RSI): | 32.85 | Sell |
Chaikin Money Flow: | -663721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.08 - 30.1) | Sell |
Bollinger Bands (100): | (27.94 - 40.34) | Sell |
RGNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 36.19 | Sell |
Chaikin Money Flow: | 5857711 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.41 - 9.97) | Sell |
Bollinger Bands (100): | (9.16 - 12.08) | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.49 | Sell |
20-day SMA: | 27.76 | Sell |
50-day SMA: | 29.64 | Sell |
200-day SMA: | 32.64 | Sell |
8-day EMA: | 25.5 | Sell |
20-day EMA: | 27.14 | Sell |
50-day EMA: | 29.52 | Sell |
200-day EMA: | 30.19 | Sell |
RGNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.27 | Sell |
20-day SMA: | 9.07 | Sell |
50-day SMA: | 9.56 | Sell |
200-day SMA: | 13.31 | Sell |
8-day EMA: | 8.2 | Sell |
20-day EMA: | 8.85 | Sell |
50-day EMA: | 9.58 | Sell |
200-day EMA: | 12.46 | Sell |
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and a decrease next year of $0.11 per share.
Regenxbio Earnings Growth & RGNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.
Dyne Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regenxbio Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |